ArticleThe International journal of angiology : official publication of the International College of Angiology, Inc2026
Peripheral Arterial Interventions with Reduced Contrast Use: The Save Contrast Study.
Article in The International journal of angiology : official publication of the International College of Angiology, Inc, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Contrast volume is a predictor of the occurrence of radiocontrast nephropathy and is associated with a high rate of in-hospital mortality and morbidity. Several strategies have been outlined to reduce contrast volume in the angiographic laboratory. Peripheral arterial endovascular procedures can be lengthy and tend to be associated with the use of high volumes of contrast. In this study, we tested specific interventions intended to reduce contrast volume in the angiographic laboratory during peripheral arterial procedures. Materials and Methods: Fifty consecutive procedures (36 patients) who underwent peripheral arterial interventions at a single center were retrospectively reviewed for demographics, clinical, procedural, and major adverse events (MAE) immediately prior to the implementation of a prospective protocol to reduce contrast use in the angiographic laboratory (group A). Following protocol implementation, 50 additional consecutive procedures (42 patients) were prospectively enrolled (group B). The protocol required diluting contrast concentration to a 2:1 dilution for larger vessels and 3:1 for infrapopliteal vessels, the use of selective injections, digital subtraction angiography, a ruler, road mapping, and intravascular ultrasound. The primary endpoint was acute procedural success, defined as achieving <30% residual narrowing with no intraprocedural complications. A primary safety endpoint was MAE at 30 days, which included unplanned amputation, total mortality, or target lesion revascularization. Descriptive and comparative analyses were performed between the two groups. Results: In groups A and B, 14 and 8 patients had staged procedures, respectively, and were analyzed only once for demographics and clinical characteristics. All patients were analyzed for clinical, angiographic, procedural, and 30-day outcomes. No differences were found in total treated length (mm) or chronic limb-threatening ischemia ( Conclusion: Contrast use can be significantly reduced during peripheral arterial interventions with the implementation of a few simple measures. A statistically nonsignificant decrease in procedural success and an increase in distal embolizations and perforations were noted in the low contrast group. Larger, randomized studies are needed to determine the overall safety of this low contrast approach in peripheral arterial interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.